Style | Citing Format |
---|---|
MLA | Liu Y, et al.. "The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials." Diabetology and Metabolic Syndrome, vol. 16, no. 1, 2024, pp. -. |
APA | Liu Y, Han F, Xia Z, Sun P, Rohani P, Amirthalingam P, Sohouli MH (2024). The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. Diabetology and Metabolic Syndrome, 16(1), -. |
Chicago | Liu Y, Han F, Xia Z, Sun P, Rohani P, Amirthalingam P, Sohouli MH. "The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials." Diabetology and Metabolic Syndrome 16, no. 1 (2024): -. |
Harvard | Liu Y et al. (2024) 'The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials', Diabetology and Metabolic Syndrome, 16(1), pp. -. |
Vancouver | Liu Y, Han F, Xia Z, Sun P, Rohani P, Amirthalingam P, et al.. The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. Diabetology and Metabolic Syndrome. 2024;16(1):-. |
BibTex | @article{ author = {Liu Y and Han F and Xia Z and Sun P and Rohani P and Amirthalingam P and Sohouli MH}, title = {The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials}, journal = {Diabetology and Metabolic Syndrome}, volume = {16}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Liu Y AU - Han F AU - Xia Z AU - Sun P AU - Rohani P AU - Amirthalingam P AU - Sohouli MH TI - The Effects of Bupropion Alone and Combined With Naltrexone on Weight Loss: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials JO - Diabetology and Metabolic Syndrome VL - 16 IS - 1 SP - EP - PY - 2024 ER - |